Recommended Topic Related To:

Cataflam

"Jan. 12, 2011 -- A new study weighs in on the debate over the relative safety of nonsteroidal anti-inflammatory medications (NSAIDs), commonly used to treat joint and muscle aches and pain.

The study, published online in the BMJ,"...

Cataflam

INDICATIONS

Carefully consider the potential benefits and risks of Cataflam® (diclofenac potassium immediate-release tablets) (diclofenac potassium immediate-release tablets) and other treatment options before deciding to use Cataflam (diclofenac potassium immediate-release tablets) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

Cataflam (diclofenac potassium immediate-release tablets) is indicated:

  • For treatment of primary dysmenorrhea
  • For relief of mild to moderate pain
  • For relief of the signs and symptoms of osteoarthritis
  • For relief of the signs and symptoms of rheumatoid arthritis

DOSAGE AND ADMINISTRATION

Carefully consider the potential benefits and risks of Cataflam® (diclofenac potassium immediate-release tablets) (diclofenac potassium immediate-release tablets) and other treatment options before deciding to use Cataflam (diclofenac potassium immediate-release tablets) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

After observing the response to initial therapy with Cataflam (diclofenac potassium immediate-release tablets) , the dose and frequency should be adjusted to suit an individual patient's needs.

For treatment of pain or primary dysmenorrhea the recommended dosage is 50 mg t.i.d. With experience, physicians may find that in some patients an initial dose of 100 mg of Cataflam (diclofenac potassium immediate-release tablets) , followed by 50-mg doses, will provide better relief.

For the relief of osteoarthritis the recommended dosage is 100-150 mg/day in divided doses, 50 mg b.i.d. or t.i.d.

For the relief of rheumatoid arthritis the recommended dosage is 150-200 mg/day in divided doses, 50 mg t.i.d. or q.i.d.

Different formulations of diclofenac [Voltaren® (diclofenac sodium enteric-coated tablets); Voltaren®-XR (diclofenac sodium extended-release tablets); Cataflam® (diclofenac potassium immediate-release tablets)] are not necessarily bioequivalent even if the milligram strength is the same.

HOW SUPPLIED

Cataflam® (diclofenac potassium immediate-release tablets)

50 mg – light brown, round, biconvex, sugar-coated tablets (imprinted Cataflam (diclofenac potassium immediate-release tablets) on one side and 50 on the other side in black ink)

Bottles of 100....NDC 0078-0436-05 Do not store above 30°C (86°F).

Dispense in tight container (USP).

Manufactured by: Patheon Inc., Whitby Operations Ontario, Canada L1N 5Z5. Distributed by: Novartis Pharmaceuticals Corporation East Hanover , New Jersey 07936. REV: February 2011

Last reviewed on RxList: 4/7/2011
This monograph has been modified to include the generic and brand name in many instances.

A A A

Cataflam - User Reviews

Cataflam User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Cataflam sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Chronic Pain/Back Pain

Find tips and advances in treatment.